DAMORA THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $117.2M | $62.6M |
| FY2022 | — | $61.8M | $32.8M |
| FY2023 | — | $32.3M | $21.5M |
| FY2024 | — | $15.8M | $14.2M |
| FY2025 | — | $240.4M | $257.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $117.2M | $62.6M |
| FY2022 | — | $61.8M | $32.8M |
| FY2023 | — | $32.3M | $21.5M |
| FY2024 | — | $15.8M | $14.2M |
| FY2025 | — | $240.4M | $257.6M |